Arcturus Therapeutics Holdings (ARCT) Prepaid Assets (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) reported Prepaid Assets of $4.2 million for Q1 2026, down 52.54% on a YoY basis from $8.8 million in Q1 2025, and down 16.27% quarter-over-quarter from $5.0 million in Q4 2025.
Arcturus Therapeutics Holdings (ARCT) Prepaid Assets (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings has reported Prepaid Assets for 9 years, with the latest figure at $4.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 52.54% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 52.54% YoY), and the FY2025 full-year result was $5.0 million, down 50.16% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.2 million, down from $5.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $10.0 million in Q4 2024, with the low at $3.6 million in Q1 2022.
- Historically, Prepaid Assets has averaged $6.5 million across 5 years, with a median of $5.9 million in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 216.17% — and 2026, when it sank 52.54%.
- Arcturus Therapeutics Holdings' Prepaid Assets stood at $8.7 million in 2022, then fell by 13.41% to $7.5 million in 2023, then surged by 32.66% to $10.0 million in 2024, then slumped by 50.16% to $5.0 million in 2025, then dropped by 16.27% to $4.2 million in 2026.
- The last three Prepaid Assets figures came in at $4.2 million (Q1 2026), $5.0 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.16 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 5.89 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 8.77 Mn |
| Dec 31, 2024 | 9.98 Mn |
| Sep 30, 2024 | 8.44 Mn |
| Jun 30, 2024 | 7.59 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 7.52 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 4.14 Mn |
| Dec 31, 2022 | 8.69 Mn |
| Sep 30, 2022 | 6.96 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.07 Mn |
| Jun 30, 2021 | 2.30 Mn |